PARNAX LAB LTD. (PARNAXLAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

PARNAXLABUpdated 18 Aug 2026, 2:23

Parnax Lab Ltd.

Market Cap

₹136Cr.

Current Price

₹118

High / Low

₹182/99.2

Stock P/E

88.7

ROE4.00%
ROCE3.09%
Book Value₹20.4
Face Value₹10.0
Dividend Yield0.00%

About

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days249.47382.94233.66254.24140.6097.9066.2294.9552.7728.9444.2023.12
Inventory Days50.6328.4236.1055.0247.7612.70145.0084.8160.83108.7794.5896.05
Days Payable72.9332.8697.60173.1198.9388.07285.00122.3845.1085.81162.4952.83
Cash Conversion Cycle227.17378.50172.15136.1589.4322.53-73.7857.3868.5051.91-23.7166.35
Working Capital Days170.99203.52-137.57213.97191.22-153.03-840.89-297.10164.67319.87399.32535.11
ROCE %-1.13%-1.13%1.43%-4.39%2.84%5.07%-2.55%7.83%8.82%12.45%8.60%3.09%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 August 2026 at 2:23


Designed & Shipped by Harshit Bansal